122 related articles for article (PubMed ID: 31556760)
21. Protocol for the treatment of cystoid macular edema secondary to retinitis pigmentosa and other inherited retinal dystrophies.
Català-Mora J; Santamaría Álvarez JF; Kyriakou D; Alforja S; Barraso Rodrigo M; Blasco Palacio PB; Casaroli-Marano R; Cobos Martín E; Coco Martín RM; Esmerado C; García Tirado A; García P; Gómez-Benlloch A; Rodríguez Fernández CA; Vilaplana Mira F
Arch Soc Esp Oftalmol (Engl Ed); 2024 Feb; 99(2):67-81. PubMed ID: 37940089
[TBL] [Abstract][Full Text] [Related]
22. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
23. Novel mutation in
Ahn J; Chiang J; Gorin MB
Ophthalmic Genet; 2020 Aug; 41(4):386-389. PubMed ID: 32594822
[TBL] [Abstract][Full Text] [Related]
24. [Genotype-Phenotype Correlations in Patients with CRB1 Mutations].
Papadopoulou Laiou C; Preising MN; Bolz HJ; Lorenz B
Klin Monbl Augenheilkd; 2017 Mar; 234(3):289-302. PubMed ID: 28355663
[No Abstract] [Full Text] [Related]
25. Extending the Spectrum of EYS-Associated Retinal Disease to Macular Dystrophy.
Pierrache LHM; Messchaert M; Thiadens AAHJ; Haer-Wigman L; de Jong-Hesse Y; van Zelst-Stams WAG; Collin RWJ; Klaver CCW; van den Born LI
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2049-2063. PubMed ID: 31074760
[TBL] [Abstract][Full Text] [Related]
26. Early onset retinal dystrophy due to mutations in LRAT: molecular analysis and detailed phenotypic study.
Dev Borman A; Ocaka LA; Mackay DS; Ripamonti C; Henderson RH; Moradi P; Hall G; Black GC; Robson AG; Holder GE; Webster AR; Fitzke F; Stockman A; Moore AT
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3927-38. PubMed ID: 22570351
[TBL] [Abstract][Full Text] [Related]
27. Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects.
Nikopoulos K; Farinelli P; Giangreco B; Tsika C; Royer-Bertrand B; Mbefo MK; Bedoni N; Kjellström U; El Zaoui I; Di Gioia SA; Balzano S; Cisarova K; Messina A; Decembrini S; Plainis S; Blazaki SV; Khan MI; Micheal S; Boldt K; Ueffing M; Moulin AP; Cremers FPM; Roepman R; Arsenijevic Y; Tsilimbaris MK; Andréasson S; Rivolta C
Am J Hum Genet; 2016 Sep; 99(3):770-776. PubMed ID: 27588451
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of topical dorzolamide therapy for cystoid macular edema in a patient with MFRP-related nanophthalmos-retinitis pigmentosa-foveoschisis-optic disk drusen syndrome.
Zacharias LC; Susanna R; Sundin O; Finzi S; Susanna BN; Takahashi WY
Retin Cases Brief Rep; 2015; 9(1):61-3. PubMed ID: 25383852
[TBL] [Abstract][Full Text] [Related]
29. Recessive pediatric-onset cone-rod dysfunction or dominant maculopathy in a consanguineous family harboring the peripherin mutation p.Arg220Gln.
Khan AO
Ophthalmic Genet; 2019 Feb; 40(1):60-63. PubMed ID: 30822235
[TBL] [Abstract][Full Text] [Related]
30. IMPG2-associated retinitis pigmentosa displays relatively early macular involvement.
van Huet RA; Collin RW; Siemiatkowska AM; Klaver CC; Hoyng CB; Simonelli F; Khan MI; Qamar R; Banin E; Cremers FP; Theelen T; den Hollander AI; van den Born LI; Klevering BJ
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3939-53. PubMed ID: 24876279
[TBL] [Abstract][Full Text] [Related]
31. Significant macular edema in a patient with cone dystrophy and improvement with acetazolamide treatment.
Gelman SK; Gorin MB
Retin Cases Brief Rep; 2014; 8(4):300-5. PubMed ID: 25372533
[TBL] [Abstract][Full Text] [Related]
32. Novel clinical findings in autosomal recessive NR2E3-related retinal dystrophy.
Murro V; Mucciolo DP; Sodi A; Passerini I; Giorgio D; Virgili G; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):9-22. PubMed ID: 30324420
[TBL] [Abstract][Full Text] [Related]
33. Topical carbonic anhydrase inhibitors in macular edema associated with Alström syndrome.
Larrañaga-Fragoso P; Pastora N; Bravo-Ljubetic L; Peralta J; Abelairas-Gómez J
Ophthalmic Genet; 2016 Dec; 37(4):427-429. PubMed ID: 26894450
[TBL] [Abstract][Full Text] [Related]
34. Paradoxical response to carbonic anhydrase inhibitors in patients with intraretinal cystoid spaces.
Guimaraes TAC; Capasso JE; Levin AV
Ophthalmic Genet; 2019 Jun; 40(3):213-218. PubMed ID: 31266384
[No Abstract] [Full Text] [Related]
35. Treatment of cystoid macular edema in homozygous twins with glutathione synthetase deficiency and retinal dystrophy.
Fakhoury O; Conrath J; Donnadieu B; Warrak R; Matonti F
J Fr Ophtalmol; 2018 Feb; 41(2):116-121. PubMed ID: 29395598
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics of rod and cone photoreceptor dystrophies in patients with mutations in the C8orf37 gene.
van Huet RA; Estrada-Cuzcano A; Banin E; Rotenstreich Y; Hipp S; Kohl S; Hoyng CB; den Hollander AI; Collin RW; Klevering BJ
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4683-90. PubMed ID: 23788369
[TBL] [Abstract][Full Text] [Related]
37. Rod-Cone Dystrophy with Initially Preserved Visual Acuity Despite Early Macular Involvement Suggests Recessive CERKL Mutations.
Khan AO; Abu-Safieh L
Ophthalmic Genet; 2015; 36(4):369-72. PubMed ID: 24547929
[TBL] [Abstract][Full Text] [Related]
38. Ophthalmological phenotype associated with homozygous null mutation in the NEUROD1 gene.
Orosz O; Czeglédi M; Kántor I; Balogh I; Vajas A; Takács L; Berta A; Losonczy G
Mol Vis; 2015; 21():124-30. PubMed ID: 25684977
[TBL] [Abstract][Full Text] [Related]
39. Detection of CRB1 mutations in families with retinal dystrophy through phenotype-oriented mutational screening.
Li S; Shen T; Xiao X; Guo X; Zhang Q
Int J Mol Med; 2014 Apr; 33(4):913-8. PubMed ID: 24535598
[TBL] [Abstract][Full Text] [Related]
40. Detailed retinal phenotype of Boucher-Neuhäuser syndrome associated with mutations in
O'Neil E; Serrano L; Scoles D; Cunningham KE; Han G; Chiang J; Bennett J; Aleman TS
Ophthalmic Genet; 2019 Jun; 40(3):267-275. PubMed ID: 31135245
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
